New Hampshire Oncology Hematology PA-Concord — Concord, New Hampshire

New Hampshire Oncology Hematology PA-Concord is a clinical research site located in Concord, New Hampshire, United States 03301.

Crixeo Clinical Trials Trust Score: 31/100 (FAILING). This profile has not yet been claimed by the site owner.

New Hampshire Oncology Hematology PA-Concord has participated in 108 clinical trials with 65 currently active.

Therapeutic areas: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma.

Sponsors: National Cancer Institute (NCI), Alliance Foundation Trials, LLC., SWOG Cancer Research Network.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Concord

Browse all research sites in New Hampshire · View every site in Concord

• Franklin Pierce University
• Rehabilitation Services of Concord Hospital
• Ohio State University-Telemedicine
• Payson Center for Cancer Care at Concord Hospital
• Concord Hospital Rehabilitation Services
• Fresh Start at Concord Hospital
• New Hampshire Hospital
• Concord Hospital
• New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care
• New Hampshire Oncology-Hematology PA
• Dartmouth - Hitchcock Concord

Sponsor Feasibility Report

Trust Score: 31/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Hampshire Oncology Hematology PA-Concord?

New Hampshire Oncology Hematology PA-Concord has a Crixeo Trust Score of 31/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Hampshire Oncology Hematology PA-Concord conducted?

New Hampshire Oncology Hematology PA-Concord has 108 clinical trials on record, with 65 currently active. Their work covers Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma.

Is New Hampshire Oncology Hematology PA-Concord accredited by Crixeo Clinical Trials?

New Hampshire Oncology Hematology PA-Concord has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New Hampshire Oncology Hematology PA-Concord?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.